This novel vehicle has been used in a Phase IV vaccine for canine Leishmaniasis, it is designed free of toxic sequences and its industrial scaling process has already been carried out
Some of the topics that are being worked on are search for vaccines, repositioning of drugs and development of new antivirals, and identification of new therapeutic targets
The funding has been received by the projects LipidNET, with the participation of Dr. Pérez-Sala, and EPI-CATCH, which counts with Dr. Testillano among the proposers